Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.

[1]  R. Gutzmer,et al.  Is there a therapeutic benefit of complete lymph node dissection in melanoma patients with low tumor burden in the sentinel node? , 2014, Melanoma research.

[2]  D. Coit,et al.  Observation After a Positive Sentinel Lymph Node Biopsy in Patients with Melanoma , 2014, Annals of Surgical Oncology.

[3]  Nanna B. Finnerup,et al.  Persistent postoperative pain and sensory changes following lymph node excision in melanoma patients: a topical review , 2014, Melanoma research.

[4]  S. Mocellin,et al.  Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  R. Elashoff,et al.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma. , 2014, The New England journal of medicine.

[6]  A. Luini,et al.  Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. , 2013, The Lancet. Oncology.

[7]  A. Eggermont,et al.  Completion lymph node dissection after a positive sentinel node: no longer a must? , 2013, Current opinion in oncology.

[8]  A. Testori,et al.  Prognosis in patients with sentinel node‐positive melanoma without immediate completion lymph node dissection , 2012, The British journal of surgery.

[9]  S. Leong.  Role of selective sentinel lymph node dissection in head and neck melanoma , 2011, Journal of surgical oncology.

[10]  A. Giuliano,et al.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. , 2011, JAMA.

[11]  A. Luini,et al.  Sentinel Lymph Node Biopsy in Breast Cancer: Ten-Year Results of a Randomized Controlled Study , 2010, Annals of surgery.

[12]  H. Hoekstra,et al.  Quality of Life After Axillary or Groin Sentinel Lymph Node Biopsy, With or Without Completion Lymph Node Dissection, in Patients With Cutaneous Melanoma , 2009, Annals of Surgical Oncology.

[13]  A. Eggermont,et al.  The Rotterdam criteria for sentinel node tumor load: the simplest prognostic factor? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  V. Rousson,et al.  Morbidity and Recurrence After Completion Lymph Node Dissection Following Sentinel Lymph Node Biopsy in Cutaneous Malignant Melanoma , 2008, Annals of surgery.

[15]  A. Eggermont,et al.  Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[16]  R. Elashoff,et al.  Sentinel-node biopsy or nodal observation in melanoma. , 2006, The New England journal of medicine.

[17]  H. Hoekstra,et al.  Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[18]  A. Cochran,et al.  The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma , 2004, The British journal of dermatology.

[19]  M. Ross,et al.  Complications Associated With Sentinel Lymph Node Biopsy for Melanoma , 2003, Annals of Surgical Oncology.

[20]  J. Thompson,et al.  Lymph-node metastases in patients with melanoma: what is the optimum management? , 2001, The Lancet. Oncology.

[21]  Martin F. Mihm,et al.  Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  D L Morton,et al.  Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. , 1999, Annals of surgery.

[23]  N. Cascinelli,et al.  Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial , 1998, The Lancet.

[24]  M. Mihm,et al.  Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. , 1996, Annals of surgery.

[25]  F. Sim,et al.  Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. , 1986, Mayo Clinic proceedings.

[26]  D. Reintgen,et al.  Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. , 1983, Annals of surgery.

[27]  N. Cascinelli,et al.  Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. , 1977, The New England journal of medicine.

[28]  W. Jurecka,et al.  Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[29]  C. Balch.  The role of elective lymph node dissection in melanoma: rationale, results, and controversies. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  W. McCarthy,et al.  Efficacy of elective lymph node dissection in 2,347 patients with clinical stage I malignant melanoma. , 1985, Surgery, gynecology & obstetrics.

[31]  U. Veronesi.  Regional lymph node dissection in melanoma of the limbs. Stage I. A cooperative international trial (WHO Collaborating Centers for diagnosis and treatment of melanoma). , 1977, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.